Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
about
Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Depletion of pro-oncogenic RUN ...... uction of pro-apoptotic TAp63.
@en
Depletion of pro-oncogenic RUNX2 enhances gemcitabine
@nl
type
label
Depletion of pro-oncogenic RUN ...... uction of pro-apoptotic TAp63.
@en
Depletion of pro-oncogenic RUNX2 enhances gemcitabine
@nl
prefLabel
Depletion of pro-oncogenic RUN ...... uction of pro-apoptotic TAp63.
@en
Depletion of pro-oncogenic RUNX2 enhances gemcitabine
@nl
P2093
P2860
P356
P1433
P1476
Depletion of pro-oncogenic RUN ...... duction of pro-apoptotic TAp63
@en
P2093
Kiriko Hiraoka
Meijie Sang
Meixiang Sang
Mizuyo Nakamura
Osamu Shimozato
Takehiro Ogata
Toshinori Ozaki
P2860
P304
71937-71950
P356
10.18632/ONCOTARGET.12433
P407
P577
2016-11-01T00:00:00Z